Objective. To determine the ability of T lymphocytes and natural killer (NK) cells from patients with systemic sclerosis (SSc) to respond to cytokines and to generate immune effector cells. Methods. The numbers and percentages of peripheral blood T and NK cells were examined by 2-color flow cytometr
IMPAIRED LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY IN PATIENTS WITH HYPOGAMMAGLOBULINAEMIA
✍ Scribed by Gao, L.; Malkovský, M.; Webster, A.D.B.; Asherson, G.L.
- Book ID
- 122641153
- Publisher
- The Lancet
- Year
- 1985
- Tongue
- English
- Weight
- 143 KB
- Volume
- 326
- Category
- Article
- ISSN
- 0140-6736
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Our expanding knowledge of the immune system has provided a basis of rationality for immunotherapy . Some non-specific immunotherapy has achieved the status of standard treatment: interferon in hairy cell leukemia and chronic myelogenous leukemia, BCG in bladder cancer, and levamisole in colon cance
Lymphokine-activated killer cells were generated from peripheral blood mononuclear cells of 33 patients with liver tumors (benign, 6; primary malignant, 10; metastatic, 17) and 10 healthy individuals. Although peripheral blood mononuclear cell yield was significantly lower (p < 0.01) in patients wit